Evidence map›Paper›PMID 11861234›Full record

ArticleArchives of disease in childhood2002

Inhaler devices for asthma: do we follow the guidelines?

F Child, S Davies, S Clayton, A A Fryer, W Lenney

Open access · bronzeAbstract read
In one paragraph

Article in Archives of disease in childhood, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Review
  3. [Wheezing in infants and toddlers: new insights].Wiener klinische Wochenschrift · 2004
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

F ChildAcademic Department of Paediatrics, City General Hospital (North Staffordshire Royal Infirmary), Newcastle Road, Stoke-on-Trent ST4 6QG, UK.
S Davies
S Clayton
A A Fryer
W Lenney

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDespite national guidelines for asthma treatment, many children have troublesome symptoms.

aimTo assess the extent to which the use of inappropriate inhaler devices contributes to this problem.

methodsOf 14 813 questionnaires distributed to schoolchildren, 6996 (47%) were returned identifying 1444 children using asthma inhalers. Inhalers were categorised as age appropriate or inappropriate according to national guidelines and were compared with those used by 75 patients attending a hospital clinic.

resultsA total of 35% of "schools" and 4% of "clinic" children reported using an inappropriate inhaler device. Most were using metered dose inhalers alone. Twenty four per cent of "schools" children < or = 5 years old did not use a spacer. Both children and parents overestimated the child's ability to use their inhaler.

conclusionsLarge numbers of children are given inhalers they cannot use. To improve asthma care we must ensure that prescriptions reflect the age and ability of the child. Recent recommendations by the Department of Health in England and Wales stress the importance of seamless care between primary and secondary services. As the management of childhood asthma is guided primarily by secondary care providers, it is therefore imperative that general paediatricians know the difficulties and issues which are occurring in the community. This will enable them to lead and support necessary change.

Indexed as

Administration, InhalationAdolescentAnti-Asthmatic AgentsAsthmaChildChild, PreschoolEquipment FailureGuideline AdherenceHumansInfantInfant, NewbornNebulizers and VaporizersPractice Guidelines as TopicSchool Health ServicesSurveys and QuestionnairesAnti-Asthmatic Agents

Identifiers

PMID11861234
PMCPMC1719133
OpenAlexW2153992985

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.